Skip to content

HIV replication can continue in the intestines even with successful antiretroviral therapy

PrEP could prevent up to three million HIV infections in ten years in Africa

Urinary stones a rare side-effect of atazanavir

Sexual transmission of hepatitis C in HIV-positive gay men reported in Australia

Merck HIV vaccine fails, trials halted

ICAAC: Gains in limb fat and CD4 counts continue three years after switching from d4T to tenofovir

ICAAC: Cross-resistance to 3TC and FTC develops slowly with entecavir monotherapy

ICAAC: Serious but non-AIDS-defining illnesses more frequent at lower CD4 counts and higher viral loads

Return of nelfinavir's European license recommended